Search Results

Cheryl L. Willman, MD, has been named executive director of Mayo Clinic Cancer Programs and director of Mayo Clinic Comprehensive Cancer Center. In her new role, Dr. Willman will lead the expansion and strategic development of Mayo Clinic Comprehensive Cancer Center sites in the U.S. and internationally. Dr. Willman will join Mayo Clinic from University of New Mexico Comprehensive Cancer Center, where she has served as director and CEO for 20 years. Read More

The AACI Clinical Research Innovation (CRI) Steering Committee, with the assistance of peer reviewers from CRI committees, have selected three abstracts from 62 submissions for formal presentation at the 13th Annual AACI CRI Meeting, July 13-15. Winning abstract authors represent University of Cincinnati Cancer Center; University of Florida Health Cancer Center; and Vanderbilt-Ingram Cancer Center. The three winning abstracts will be presented individually during a virtual session on Wednesday,…

The University of Kansas Cancer Center Nearly 10 million cancer screenings in the U.S. failed to happen because of the COVID-19 pandemic, according to a new study. Researchers, including the first author on the study, Ronald Chen, MD, MPH, are calling for public attention to this problem to prevent cancer deaths. Read More

VCU Massey Comprehensive Cancer Center Nearly a quarter of pregnant women say they’ve been around secondhand smoke—in their homes, at work, around a friend or relative—which, according to new research, is linked to epigenetic changes in babies that could raise the risk of developmental disorders and cancer. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine When resecting tumors, surgeons aim to spare as much healthy tissue as possible while ensuring removal of the entire tumor. Pediatric surgeons at Baylor College of Medicine and Texas Children’s Hospital believe a fluorescent dye called indocyanine green paired with a near-infrared camera may be useful tools in achieving that goal. Read More

UMMC Cancer Center and Research Institute Brandon Lennep, MD, a University of Mississippi Medical Center (UMMC) assistant professor of cardiology, has been named to head the UMMC Cancer Center and Research Institute’s (CCRI) Cardio-Oncology Clinic. The clinic provides on-site services to CCRI's largest outpatient site. Read More

Fox Chase Cancer Center, Temple Health Mary B. Daly, MD, PhD, FACP, professor in the Department of Clinical Genetics and director of the Risk Assessment Program at Fox Chase Cancer Center, recently received the National Comprehensive Cancer Network’s (NCCN) Rodger Winn Award. Read More

Registration is now open for the 2021 AACI/CCAF Annual Meeting, which will take place October 19-21 in a virtual format. This three-day event convenes AACI cancer center members with national cancer research and advocacy groups, industry, and government health agencies to develop solutions to common challenges. Continuing Medical Education (CME) is jointly provided by the American Association for Cancer Research (AACR) and AACI. Read More

On March 4—International HPV Awareness Day—Representative Kathy Castor (D-FL) introduced the PREVENT HPV Cancers Act (H.R. 1550), which AACI has endorsed. We encourage cancer centers to reach out to their congressional delegations with our customizable advocacy letter to request that they co-sponsor and support the bill. Read More

Sidney Kimmel Cancer Center at Jefferson Health The American Association for Cancer Research has recognized Edith P. Mitchell, MD, with the 2021 Minorities in Cancer Research-Jane Cooke Wright Lectureship. Dr. Mitchell is the associate director for diversity affairs and director of the Center to Eliminate Disparities at the Sidney Kimmel Cancer Center at Jefferson Health. Read More

AACI's Physician Clinical Leadership Initiative (PCLI) will host The Role of the Clinical Pharmacist in an Academic Hematology/Oncology Practice at 2:00 pm eastern time on Tuesday, August 24. This webinar will cover the clinical pharmacist (CP) training and supervision requirements along with roles and responsibilities. Read More

Roswell Park Comprehensive Cancer Center Even during the COVID-19 pandemic, Roswell Park Comprehensive Cancer Center scientists have continued to draw research support, garnering more than $34 million in grants from government agencies and private funders. The grants fund efforts to improve outcomes for patients with challenging cancers like triple-negative breast cancer, pancreatic cancer, and head and neck cancers, and to advance what we know about COVID-19 in cancer patients. …

Robert Winn, MD, director of VCU Massey Cancer Center, has been elected to serve as vice president/president-elect of AACI’s board of directors. Marcia Cruz-Correa, MD, PhD; Ruben Mesa, MD, FACP; and Robert H. Vonderheide, MD, DPhil, have been elected as new board members, and Joann Sweasy, PhD, has been appointed to fill the remainder of Dr. Winn’s term as a regular board member. Read More

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center has earned renewal of its National Cancer Institute designation as a Comprehensive Cancer Center. It will receive a support grant of nearly $13 million over the next five years, a 14-percent increase over the previous five-year grant. Kevin J. Cullen, MD, is center director. Read More

Rutgers Cancer Institute of New Jersey Rutgers Cancer Institute of New Jersey Director Steven K. Libutti, MD, FACS, has been named by the business journal NJBIZ as a 2021 Healthcare Hero in the healthcare professional category. He has published more than 300 peer-reviewed articles, is editor-in-chief emeritus of the Nature Journal Cancer Gene Therapy, and holds 11 U.S. patents. Read More

Last month AACI welcomed the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine to its roster, bringing its membership number to 103. Directed by Lewis C. Cantley, PhD, the Meyer Cancer Center is a matrix cancer center organized by four research focus areas: Cancer Biology; Cancer Genetics & Epigenetics; Experimental Therapeutics; and Cancer Prevention & Control. The association also welcomed Fulgent Genetics to the AACI Corporate Roundtable. Read More

Judy E. Garber, MD, PhD, FAACR, chief of the Division of Cancer Genetics and Prevention at the Dana-Farber Cancer Institute, will receive the AACI Distinguished Scientist Award on Wednesday, October 20, during the 2021 AACI/CCAF Annual Meeting. Read More

Siteman Cancer Center Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is planning a nine-story, 659,000-square-foot facility that will provide a central home for nearly all aspects of advanced cancer care for outpatients. Timothy J. Eberlein, MD, is director of the Siteman Cancer Center. Read More

Moffitt Cancer Center The family of It Works! founder Mark Pentecost has donated $10 million to Moffitt Cancer Center to establish a research center dedicated to finding a cure for multiple myeloma. Mark and Cindy Pentecost became supporters of the cancer center after he received treatment for his own battle with the rare blood cancer. In 2018, the Pentecost family gave $3 million to help fund new innovations in myeloma research. Read More

Since President Biden first proposed the Advanced Research Projects Agency for Health (ARPA-H), the health care advocacy community has been eager to learn more. Last month, the National Institutes of Health (NIH) and the Office of Science and Technology Policy (OSTP) hosted the first of many listening sessions on the proposed creation of ARPA-H. The first session included individuals representing cancer, heart, lung, and blood disorders and environmental health. AACI Executive Director Jennifer…

Siteman Cancer Center Jeff M. Michalski, MD, MBA, vice chair and director of clinical programs in the Department of Radiation Oncology at Washington University School of Medicine in St. Louis, has been elected president-elect of the American Society for Radiation Oncology (ASTRO) board of directors. Read More

Fred Hutchinson Cancer Center Fred Hutchinson Cancer Research Center, UW Medicine, Seattle Cancer Care Alliance, and Seattle Children’s have announced plans to explore restructuring their longtime relationship to accelerate a shared mission of advancing diagnosis, treatment, and pioneering of cures for cancer and other diseases. If finalized and approved, the proposed restructure would establish an adult-focused oncology program and, separately, a pediatric oncology program. Rea…

Moffitt Cancer Center Sarabdeep “Sabi” Singh has been named executive vice president and chief operating officer of Moffitt Cancer Center. Prior to joining Moffitt, Singh served as the chief operating officer of the University of Iowa Hospitals & Clinics since 2013. Read More

University of Michigan Rogel Cancer Center Younger cancer survivors—those between ages 18 and 64—faced fewer financial barriers to health care after the Affordable Care Act was implemented than they did before the landmark law took effect, University of Michigan researchers found. Read More

Duke Cancer Institute, Duke University Medical Center Cancer deaths were lower in the five states and District of Columbia that expanded Medicaid early on as part of the Affordable Care Act, compared to states that did not expand the federal insurance, according to a study led by Duke Cancer Institute. Read More

Stanford Cancer Institute A diet rich in fermented foods enhances gut microbe diversity and decreases molecular signs of inflammation, according to Stanford researchers. In a clinical trial, 36 healthy adults were randomly assigned to a 10-week diet that included either fermented or high-fiber foods. The two diets resulted in different effects on the gut microbiome and the immune system. Read More

The University of Kansas Cancer Center A new endowed professorship at The University of Kansas Cancer Center has been named to honor Carol Fabian, MD, founder of the cancer center’s Breast Cancer Prevention and Survivorship Research Center. At $4 million, it is the second-largest professorship ever established at KU Cancer Center. Read More

VCU Massey Comprehensive Cancer Center A study led by VCU Massey Cancer Center analyzed the variation in vaccination rates among boys and girls within zip codes in Virginia. The results showed several areas of significantly lower vaccination coverage, including predominantly rural localities, and overall large geographic disparities in HPV vaccination. Read More

Cedars-Sinai Cancer Neil Bhowmick, PhD, co-leader of the Cancer Biology Program at Cedars-Sinai Cancer, was one of 10 Indian American scientists honored by the Society of Asian American Scientists in Cancer Research for his contributions to cancer research. Read More

Vanderbilt-Ingram Cancer Center Nancy Davis, MD, has been promoted to vice president for cancer care network and strategy at Vanderbilt University Medical Center, a new position responsible for developing provider relationships with other health care systems and expanding access to oncology care throughout Tennessee and other states. Read More

VCU Massey Comprehensive Cancer Center VCU Massey Cancer Center researchers Paul B. Fisher, MPh, PhD, FNAI, and Xiang-Yang (Shawn) Wang, PhD, were recently awarded $2.3 million in total funding through a five-year grant from the National Cancer Institute to understand the genetic processes that contribute to prostate cancer growth and to develop novel therapeutic strategies to effectively treat late-stage disease. Read More

Wilmot Cancer Institute, UR Medicine Lynne E. Maquat, PhD, founding director of the University of Rochester’s Center for RNA Biology, received the Warren Alpert Foundation Prize in recognition of pivotal discoveries in RNA biology. She shares the award with fellow RNA biologist Joan Seitz, PhD, of the Yale School of Medicine. Read More

UMMC Cancer Center and Research Institute Marcus Zachariah, MD, is co-lead author of a study on breast cancer brain metastasis, "HIF1A signaling selectively supports proliferation of breast cancer in the brain." He and his colleagues identified changes in metabolism critical for growth of breast cancer cells in the brain during metastasis. Read More

University of Michigan Rogel Cancer Center With a $2.26 million grant from the National Cancer Institute, Rogel Cancer Center researcher Christine Veenstra, MD, MSHP, will seek to understand the barriers to equitable use of targeted therapies among diverse patients and diverse practice settings. Read More

Cancer Center at Illinois A new approach to treating breast cancer kills 95-100 percent of cancer cells in mouse models of human estrogen-receptor-positive breast cancers and their metastases in bone, brain, liver, and lungs. The newly developed drug, called ErSO, quickly shrinks even large tumors to undetectable levels. The research team was led by scientists at the University of Illinois Urbana-Champaign. Read More

UCSF Helen Diller Family Comprehensive Cancer Center UCSF researchers are beginning to engineer much more complex living therapeutics by tapping into the innate capabilities of living cells to treat a growing list of diseases including solid tumors like cancers of the brain, breast, lung, or prostate, and also inflammatory diseases like diabetes, Crohn’s, and multiple sclerosis. Read More

Duke Cancer Institute, Duke University Medical Center Urologic surgical oncologist Michael Cookson, MD, MHA, FACS, has been appointed chief of the Duke Division of Urology. He will join Duke from the University of Oklahoma Health Sciences Center. Read More

Fox Chase Cancer Center, Temple Health Elizabeth Plimack, MD, MS, chief of the Division of Genitourinary Medical Oncology at Fox Chase Cancer Center, was recently appointed medical oncology editor for the journal European Urology. Read More

UCSF Helen Diller Family Comprehensive Cancer Center Kim Rhoads, MD, MPH, director of the Office of Community Engagement at the UCSF Helen Diller Family Comprehensive Cancer Center, founded Umoja Health Partners to unite about 30 organizations combating COVID-19 in Black communities in the Bay Area. She shares why the Umoja approach (the name comes from the Swahili word for "unity" or "oneness") is working. Read More

The Tisch Cancer Institute at Mount Sinai Mount Sinai researchers found that multiple myeloma patients mount variable and sometimes suboptimal responses after receiving the Pfizer-BioNTech or Moderna COVID-19 vaccines. The study points to the need for antibody testing and precautions for these patients after vaccination. Read More

Vanderbilt-Ingram Cancer Center Susan G. Komen has announced breast cancer research grants, including $1.2 million in funding for three separate initiatives led by Vanderbilt-Ingram Cancer Center (VICC). The grants focus on two key areas – research to better detect and treat stage IV metastatic breast cancer and research to eliminate disparities in breast cancer outcomes. Read More

Rutgers Cancer Institute of New Jersey Researchers at Rutgers Cancer Institute of New Jersey, Rutgers New Jersey Medical School, and the Center for Theoretical Biological Physics at Rice University, have demonstrated that a technology with favorable biological attributes known as phage display could be a viable platform for the development of new vaccines to protect against COVID-19. Read More

UK Markey Cancer Center A recent study demonstrated the benefit of utilizing drugs to promote radiation sensitivity in models of a rare tumor subtype. The research, conducted in the lab of Piotr Rychahou, MD, illustrates the potential benefit of using an inhibitor of PI3K/mTOR pathway, key player in tumor formation, to increase the toxic effect of radiation therapy using in vitro models. Read More

Wilmot Cancer Institute, UR Medicine A study led by Wilmot Cancer Institute researchers describes a three-step process for attacking leukemia and its significance for patients who face acute myeloid leukemia. The approach is quite different from standard methods such as chemotherapy because it allows scientists to deliver treatment that can correct faulty genes that fuel the cancer. Read More

UAMS Winthrop P. Rockefeller Cancer Institute Michael Birrer, MD, PhD, vice chancellor and director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), was invested July 15 in the Kent C. Westbrook, MD, Director’s Chair for the Winthrop P. Rockefeller Cancer Institute. Read More

UAMS Winthrop P. Rockefeller Cancer Institute A highly specialized UAMS research team that serves as a national resource recently helped the University of North Carolina discover a key driver of cancer cell development. The discovery, which gives researchers a new target for drug therapies, put an exclamation mark on a successful first year for the UAMS team, called the IDeA National Resource for Quantitative Proteomics. Read More

The Tisch Cancer Institute at Mount Sinai Myron Schwartz, MD, is director of the new Center of Excellence for Liver and Bile Duct Cancer at Mount Sinai’s Tisch Cancer Institute. Read More

Huntsman Cancer Institute at the University of Utah Huntsman Cancer Institute (HCI) at the University of Utah has announced the appointment of Howard Colman, MD, PhD, as the new co-leader of the Experimental Therapeutics Program. Dr. Colman also directs HCI's Computational Oncology Research Initiative. Read More

The University of Texas MD Anderson Cancer Center Researchers from The University of Texas MD Anderson Cancer Center found specific intestinal microbiota signatures correlate with high-grade adverse events and response to combined CTLA-4 and PD-1 blockade treatment. They also identified a potential new strategy to treat toxicity—while maintaining response—to combined immune checkpoint blockade through either IL-1R inhibition or manipulation of the gut microbiota. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute. Read More

Stanford Cancer Institute Investigators at the Stanford University School of Medicine and the Buck Institute for Research on Aging have built an inflammatory-aging clock that can predict how strong your immune system is, how soon you’ll become frail, or whether you have unseen cardiovascular problems that could become clinical headaches a few years down the road. Read More

Ellen and Ronald Caplan Cancer Center of The Wistar Institute A study by The Wistar Institute describes an important function of alternative polyadenylation (APA) in allowing certain mRNAs to reach specific sites of protein synthesis and reveals that length, sequence, and structural properties can determine the destination (and fate) of mRNAs within the cell. Read More

Roswell Park Comprehensive Cancer Center A research team led by Fumito Ito, MD, PhD, FACS, of Roswell Park Comprehensive Cancer Center reports new data on the promise of combining standard treatment for breast cancer with a particular form of cancer immmunotherapy – dendritic-cell treatment vaccines. Read More

University of New Mexico Comprehensive Cancer Center A UNM Comprehensive Cancer Center study, led by Stephanie Fine, MD, compared three-dimensional tomosynthesis mammography to digital mammography. Over the three-year study period, women who had 3D breast examinations saw, on average, a 30-percent reduction in the number of callbacks over women who used traditional two-dimensional exams. Read More

University of New Mexico Comprehensive Cancer Center Like a mystery detective, Sara G.M. Piccirillo, PhD, is hunting deadly bad actors in brain cancer and immune cells by studying the crime scene and questioning bystanders one by one. Using $850,000 in grant funding, she is focusing on residual disease and macrophages. Read More

Fox Chase Cancer Center, Temple Health Three researchers from the Fox Chase Cancer Prevention and Control Program were recognized by Temple University with the Social & Behavioral Sciences Community Partner Outstanding Supervisor Award. This year’s honorees were Jennifer Barsky Reese, PhD; Linda Fleisher, PhD, MPH; and Suzanne M. Miller, PhD. Read More

Huntsman Cancer Institute at the University of Utah A new study reports that one third of the most popular cancer treatment articles on social media contain misinformation. Further, the vast majority of that misinformation has the potential to harm cancer patients by supporting approaches that could negatively impact the quality of their treatment and chances for survival. Read More

The Tisch Cancer Institute at Mount Sinai The Mount Sinai Health System has announced a $60 million gift from James S. and Merryl H. Tisch to establish the Mount Sinai Tisch Cancer Center. This gift will support the construction of a modern, state-of-the-art cancer hospital at the Mount Sinai Hospital campus. Read More

UK Markey Cancer Center The University of Kentucky Markey Cancer Center launched a new initiative to create a connected, integrated statewide cancer provider network. The initiative, which include upgraded cancer conference facilities and a comprehensive cancer care platform, will help ensure the delivery of quality cancer care close to home. Read More

Cedars-Sinai Cancer Cedars-Sinai investigators have identified a subtype of cancer cells that could help predict how bladder cancers respond to certain therapies. Dan Theodorescu, MD, PhD, director of Cedars-Sinai Cancer, is co-senior author of the study. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Baylor College of Medicine has been awarded more than $20.7 million through 11 grants from the Cancer Prevention & Research Institute of Texas (CPRIT) to support innovative cancer research, treatment, prevention measures, and community outreach. Read More

The University of Texas MD Anderson Cancer Center A study led by Kevin Nead, MD, and researchers from The University of Texas MD Anderson Cancer Center found a significant association between cholesterol-lowering drugs commonly known as statins and survival rates of triple-negative breast cancer patients. Read More

University of Florida Health Cancer Center UF Health Cancer Center Director Jonathan Licht, MD, has received the 2021 American Society of Hematology (ASH) Mentor Award. The ASH Honorific Awards are the society’s most prestigious awards, recognizing individuals within the global hematology community who have made significant contributions to the field. Read More

Wilmot Cancer Institute, UR Medicine When Tracy Downs decided to quit smoking, she had little faith that it would actually happen. Having smoked for 26 years, including while she received treatment for breast cancer in 2020, she had tried a lot of tactics but nothing seemed to stick. Read More

City of Hope Comprehensive Cancer Center Cancer Care Is Different, a coalition-based campaign effort to improve patient access to advanced cancer care in California, applauds the state Assembly’s unanimous passage of the Cancer Patients Bill of Rights on August 19, joining the state Senate in adopting this resolution. Read More

Vanderbilt-Ingram Cancer Center Ben Ho Park, MD, PhD, has been named deputy director of Vanderbilt-Ingram Cancer Center. His elevation to deputy director follows his promotion to director of the Division of Hematology and Oncology at Vanderbilt University Medical Center in October 2020. He will continue to lead the division in addition to serving in the new position. Read More

Roswell Park Comprehensive Cancer Center An influential figure in cancer immunotherapy has returned to his Western New York roots to take on leadership roles at Roswell Park Comprehensive Cancer Center. Renier Brentjens, MD, PhD, starts in September as deputy director and chair of medicine. He joins Roswell Park from Memorial Sloan Kettering Cancer Center, where he served as director of cellular therapeutics. Read More

AACI will honor Robert A. Winn, MD, with the inaugural AACI Cancer Health Equity Award during the 2021 AACI/CCAF Annual Meeting, which will be held virtually October 19-21. Dr. Winn is AACI’s vice president/president-elect and director of VCU Massey Cancer Center. Read More

UK Markey Cancer Center UK HealthCare recently launched a new Pediatric Neuroendocrine Tumor Clinical and Research Program to improve treatment for children diagnosed with or at high risk for developing rare neuroendocrine tumors. This program, a joint effort between the University of Kentucky Markey Cancer Center and the Kentucky Children’s Hospital, is one of only a handful of centers specializing in this field. Read More

University of Virginia Cancer Center After reviewing outcomes of almost 14,000 patients with colorectal cancer, researchers determined that ACE inhibitors, beta-blockers, and thiazide diuretics were all associated with decreased mortality. Rajesh Balkrishnan, PhD, led the research. Read More

The University of Chicago Medicine Comprehensive Cancer Center University of Chicago researchers have found lasofoxifene outperformed fulvestrant, the current gold-standard drug, in reducing or preventing primary breast cancer tumor growth in mice. The drug also was more effective at preventing metastasis in the lung, liver, bone, and brain. Geoffrey Greene, PhD, is senior author on the study. Read More

Duke Cancer Institute, Duke University Medical Center Shelley Hwang, MD, MPH, has been named interim director of the Breast Cancer Disease Group at Duke Cancer Institute. In 2016, Time magazine named Dr. Hwang one of the 100 most influential people for her work in reframing the problem of pre-invasive breast cancer. Read More

Moffitt Cancer Center Moffitt Cancer Center researchers have described a prediction model they have created that includes information calculated from computed tomography images that can identify patients who are not likely to respond to immunotherapy. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Gregory Riggins, MD, PhD, and his team used two different mouse models to determine that the anti-parasitic drug mebendazole could slow or stop the growth and spread of both early and late-stage pancreatic cancer. Read More

Stanford Cancer Institute Great strides have been made in recent years combining artificial intelligence (AI) and medical imaging to improve cancer diagnosis. Now a research team led by Stanford and including researchers from Texas, England, and Japan are using AI to help oncologists improve treatment for their patients. Read More

Vanderbilt-Ingram Cancer Center A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients, according to a new study conceived and designed by Justin Balko, PharmD, PhD. Read More

The Tisch Cancer Institute at Mount Sinai The Icahn School of Medicine at Mount Sinai has been awarded a grant of more than $4 million by the National Cancer Institute for a large-scale study to evaluate anal cancer screening in high-risk women who have been previously diagnosed with human papillomavirus infection. The study is a collaboration between Mount Sinai, The University of Texas MD Anderson Cancer Center, and The University of Texas Health Science Center at Houston. Re…

Rutgers Cancer Institute of New Jersey The fiscal year 2022 New Jersey state budget included a $10 million appropriation to support pediatric cancer research. This legislation will support the establishment of the Pediatric Cancer Center at Rutgers Cancer Institute of New Jersey. Read More

Fox Chase Cancer Center, Temple Health David S. Weinberg, MD, MSc, chair of the Department of Medicine at Fox Chase Cancer Center, was recently named one of two new editors-in-chief of Gastroenterology, the premier journal of the American Gastroenterological Association. Read More

Siteman Cancer Center Carmen R. Bergom, MD, PhD, a Washington University associate professor of radiation oncology at Siteman Cancer Center, has been elected to a three-year term as a councilor-at-large for the Radiation Research Society. Read More

University of Michigan Rogel Cancer Center It’s a scientific riddle tangled up in a complex web. How do you turn an immune cold cancer into one that responds to immunotherapy? Researchers led by the University of Michigan Rogel Cancer Center started with a simple thread: an inhibitor that showed promise against metastatic castration-resistant prostate cancer cells. Read More

Huntsman Cancer Institute at the University of Utah New research reports how two separate DNA changes appear to predict aggressive childhood leukemias when they occur in combination. Over the course of a decade, work in several study sites spanning multiple continents evaluated tumor characteristics of more than 1,300 childhood cancer patients who were diagnosed with B-cell acute lymphoblastic leukemia. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a Phase I clinical trial led by the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer C…

UCLA Jonsson Comprehensive Cancer Center Beth Karlan, MD, director of cancer populations at the UCLA Jonsson Comprehensive Cancer Center, is being honored with the Lifetime Achievement Award from the International Gynecologic Cancer Society for her contributions to gynecologic cancer research and clinical practice. Read More

City of Hope Comprehensive Cancer Center City of Hope researchers looked at the most common type of metastatic colorectal cancer and discovered that these patients are more responsive to checkpoint blockade immunotherapy, an innovative treatment that helps the immune system recognize and attack cancerous cells, if tumors have not spread to the liver. Read More

Fred Hutchinson Cancer Center In the wake of findings that COVID-19 virus variants are more likely to spring from patients with weakened immune systems, Lawrence Corey, MD, and other leading medical experts are calling for heightened precautions in the treatment of such individuals and better, more intensive therapies to help them fully recover from their disease. Read More

University of Florida Health Cancer Center Researchers at the University of Florida Health Cancer Center, the Sylvester Comprehensive Cancer Center, and Moffitt Cancer Center received a five-year, $3.95 million National Institutes of Health grant to study how uveal melanoma spreads to the liver. This work was previously supported by a Florida Academic Cancer Center Alliance pilot and two Florida Department of Health Biomedical Research Program Bankhead-Coley grants. Read More

UAMS Winthrop P. Rockefeller Cancer Institute Mayumi Nakagawa, MD, PhD, was awarded $3.6 million from the National Cancer Institute to complete Phase II clinical trials of PepCan, a breakthrough vaccine she developed at UAMS to treat cancers caused by human papillomavirus (HPV). Read More

Stanford Cancer Institute CAR T-cell therapy works for many types of blood cancers, but more than half of patients relapse. Stanford researchers studied whether simultaneously targeting two molecules, CD19 and CD22, would make it more difficult for cancer cells to evade the treatment. But they found it was difficult to engineer CAR T cells that were equally potent against each target. Read More

The University of Chicago Medicine Comprehensive Cancer Center New research from the University of Chicago shows that low doses of a four-drug combination help prevent the spread of cancer in mice without triggering drug resistance or recurrence. The findings suggest a new approach to preventing cancer metastasis in patients by simultaneously targeting multiple pathways within a metastasis-promoting network. Read More

AACI invites you to promote your cancer center by purchasing an ad in the 2021 AACI/CCAF Annual Meeting program. The digital program book offers an excellent opportunity to showcase your center while supporting the annual meeting. Your cancer center’s program ad may highlight a conference or a new initiative. Cancer centers may also include links to their website and any upcoming events. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute The global COVID-19 pandemic has forced many people to live in relative isolation for more than a year. As adolescents return to school, public health experts caution parents to pay close attention to signs of tobacco use among teens. Read More

Wilmot Cancer Institute, UR Medicine A new study shows that women newly diagnosed with breast cancer, who were exercising moderately or vigorously before chemotherapy (getting the recommended 150 minutes per week), were less likely to suffer from "chemo brain" during and after treatment. Michelle Janelsins, PhD, MPH, is senior author of the study. Read More

Sidney Kimmel Cancer Center at Jefferson Health Patients with various forms of pancreatic disease are more likely to experience depression, anxiety, and other conditions that negatively impact their quality of life, according to new research from Thomas Jefferson University, suggesting that treating underlying conditions may be particularly important in this group of patients. Read More

University of Virginia Cancer Center A drug used to treat certain advanced breast cancers may offer a new treatment option for a deadly blood cancer known as myelofibrosis, new research from UVA Cancer Center suggests. The drug, palbociclib, may be able to prevent the scarring of bone marrow that existing treatments for myelofibrosis cannot. Read More

Moffitt Cancer Center Researchers in Moffitt Cancer Center’s Lung Cancer Center of Excellence believe a combination of checkpoint inhibitors with adoptive cell therapy could be the answer for patients who do not respond well to certain types of immunotherapy for the treatment of non-small cell lung cancer. Read More

Indiana University Melvin and Bren Simon Comprehensive Cancer Center Rachel Katzenellenbogen, MD, has joined Susan Rawl, PhD, and Todd Skaar, PhD, as a co-leader of the Cancer Prevention and Control research program. She is the Chuck and Tina Pagano Scholar at the IU Simon Comprehensive Cancer Center. Read More

Sidney Kimmel Cancer Center at Jefferson Health Jefferson Health’s Sidney Kimmel Cancer Center is launching a Mobile Cancer Screening program to better serve vulnerable populations in Greater Philadelphia. The mobile unit will deploy the latest imaging technology to detect cancers of the breast, prostate, head and neck, as well as melanomas. The initiative was made possible by a $1.4 million gift from Dietz & Watson. Read More